Suchergebnisse - "Vano, Yann-Alexandre"

PubPharm (42)

1

Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care

enthalten in: British journal of cancer | 2024

von Blanchet, B. | Xu-Vuilard, A. | Jouinot, A. | +21

2

Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas

enthalten in: Cell reports. Medicine | 2023

von Lu, X. | Vano, Y. | Su, X. | +19

3

Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors : A Nonrandomized Controlled Trial

enthalten in: JAMA network open | 2023

von André, T. | Berton, D. | Curigliano, G. | +24

4

Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas

enthalten in: The oncologist | 2023

von Alhalabi, O. | Thouvenin, J. | Négrier, S. | +13

5

Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies

enthalten in: Bulletin du cancer | 2023

von Guillaume, Z. | Allory, Y. | Auclin, E. | +8

6

Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma : The CABIR study

enthalten in: International journal of cancer | 2022

von Vano, Y. | Phan, L. | Gravis, G. | +17

7

How molecularly similar are primary and metastatic tissues in renal cell carcinoma? - Authors' reply

enthalten in: The Lancet. Oncology | 2022

von Vano, Y. | Elaidi, R. | Phan, L. | +5

CommentOn: Lancet Oncol. 2022 May;23(5):612-624. - PMID 35390339

8

Optimal molecular selection to benefit from nivolumab-ipilimumab in clear-cell renal cell carcinoma

enthalten in: The Lancet. Oncology | 2022

von Vano, Y. | Elaidi, R. | Phan, L. | +4

CommentOn: Lancet Oncol. 2022 May;23(5):612-624. - PMID 35390339

9

MiTF/TFE Translocation Renal Cell Carcinomas : From Clinical Entities to Molecular Insights

enthalten in: International journal of molecular sciences | 2022

von Simonaggio, A. | Ambrosetti, D. | Verkarre, V. | +3

10

Future treatment options in metastatic clear cell renal cell carcinoma

enthalten in: Bulletin du cancer | 2022

von Simonaggio, A. | Auvray-Kuentz, M. | Rochand, A. | +4

1
2
3
4
5
Nächster »
[5]